Researchers develop ‘armored’ CAR-T with potential against solid tumors
Mouse model study uses PD-1 antibody technology from Eureka Therapeutics, which is also developing T-cell receptor therapies.
Startup gets $21M for monoclonal antibody that reaches inside the cancer cell
Most human monoclonal antibody therapies target proteins on the outer membrane of the cell – but a Bay Area startup is receiving a healthy flush of cash to further investigate its drug that reaches cancer cells on the inside. Cancer immunotherapy player Eureka Therapeutics has raised $21 million in a Series C financing round, led by […]
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.